Limpet_Chicken
Bluelighter
Has anybody assayed the effect of sunifiram (1-benzoyl-4-propionylpiperazine) in man?
I'm interested in studies, medical trials and curious nibbling, this relatively novel member of a new class of AMPAkine agents based on a piperazine backbone, which is by weight, extremely potent, what I would like to know though is, how effective it is in practise, as of course potency doesn't nescessarily equal usefulness in vivo.
I shall be undertaking the synthesis and testing of a small quantity (1g), of sunifiram, (it is at present time completely unscheduled in my country and to the best of my knowledge, anywhere else in the world, and some time in the future, quote possibly a whole series of its homologs, during the coming week in the case of DM235 itself, and in the case of experimentation, when my crappy special needs govt. income permits me to save a little funding.
I'l report back as soon as I have begun testing, as I am currently almost going under with a cognitive impairment of a memory consolidation, short term/working memory, attention span, motivation and spatial awareness kind, so hopefully the project will prove successful in reversing, or attenuating, maybe if I'm lucky even improving from my pre-onset of impairment baseline cognition.
Of particular interest to me are reports of:
Pharmacokinetics
Side effects
subjective and objective effects
Duration of action
TOLERANCE
Any persistence of cognitive enhancement or induced deficit in cognitive processes remaining post-administration for a significant time, as I have read any and every paper pertaining to AMPAkines, inhibitors of AMPA desensitisation or similar that I have been able to lay my grubby little lab-rat paws upon, well most of them at any rate, given I still have a fair few downloaded and yet to read, I am itching to start the practical work, but that doesn't mean I can't cram in every last snippet of already extant research work on DM235 that I can get in the meantime.
I'm interested in studies, medical trials and curious nibbling, this relatively novel member of a new class of AMPAkine agents based on a piperazine backbone, which is by weight, extremely potent, what I would like to know though is, how effective it is in practise, as of course potency doesn't nescessarily equal usefulness in vivo.
I shall be undertaking the synthesis and testing of a small quantity (1g), of sunifiram, (it is at present time completely unscheduled in my country and to the best of my knowledge, anywhere else in the world, and some time in the future, quote possibly a whole series of its homologs, during the coming week in the case of DM235 itself, and in the case of experimentation, when my crappy special needs govt. income permits me to save a little funding.
I'l report back as soon as I have begun testing, as I am currently almost going under with a cognitive impairment of a memory consolidation, short term/working memory, attention span, motivation and spatial awareness kind, so hopefully the project will prove successful in reversing, or attenuating, maybe if I'm lucky even improving from my pre-onset of impairment baseline cognition.
Of particular interest to me are reports of:
Pharmacokinetics
Side effects
subjective and objective effects
Duration of action
TOLERANCE
Any persistence of cognitive enhancement or induced deficit in cognitive processes remaining post-administration for a significant time, as I have read any and every paper pertaining to AMPAkines, inhibitors of AMPA desensitisation or similar that I have been able to lay my grubby little lab-rat paws upon, well most of them at any rate, given I still have a fair few downloaded and yet to read, I am itching to start the practical work, but that doesn't mean I can't cram in every last snippet of already extant research work on DM235 that I can get in the meantime.